Home > Insider Trading > Filing (0001193805-20-001005)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1368514	Adma Biologics Inc.	ADMA	Biological Products, (No Disgnostic Substances) (2836)	562590442

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1542517	S Adam Grossman	C/O Adma Biologics, Inc. 465 State Route 17 Ramsey NJ 07446	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-08-10	10	$3.06	166,108	No	4	P	Direct
Common Stock	Acquisiton	2020-08-10	2,990	$3.07	169,098	No	4	P	Direct
Common Stock	Acquisiton	2020-08-10	2,000	$3.04	171,098	No	4	P	Direct
Common Stock	Acquisiton	2020-08-11	1,000	$2.97	172,098	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	878,444	Indirect	See Footnote
Common Stock	580,957	Indirect	See Footnote

Footnotes

Includes 100,000 restricted stock units granted on February 28, 2020, which will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting.
These shares are owned by Areth, LLC ("Areth"). The reporting person is a control person of Areth.
These shares are owned by Hariden, LLC ("Hariden"). The reporting person is the managing member of Hariden.